- Featured Product
- KD/KO Validated
PABPN1 Monoklonaler Antikörper
PABPN1 Monoklonal Antikörper für WB, IHC, IF/ICC, IP, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IF/ICC, IP, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
3C12E12
Kat-Nr. : 66807-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66807-1-PBS bindet in WB, IHC, IF/ICC, IP, Indirect ELISA PABPN1 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | PABPN1 fusion protein Ag27470 |
| Vollständiger Name | poly(A) binding protein, nuclear 1 |
| Berechnetes Molekulargewicht | 33 kDa |
| Beobachtetes Molekulargewicht | 50-56 kDa |
| GenBank-Zugangsnummer | BC010939 |
| Gene symbol | PABPN1 |
| Gene ID (NCBI) | 8106 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Poly(A) Binding Protein Nuclear 1(PABPN1) is one of the isoforms of poly(A) binding protein (PABP) that locating to the nucleus in eukaryotic cells. And PABPN1 plays important role in mRNA stability by regulating of poly-A tail length, mRNA decay and proximal polyadenylation site (PAS) utilization at the 3'-UTR (PMID:23300856). Another report showed that PABPN1 shuttles between the nucleus and the cytoplasm to export poly(A) RNA from the nucleus (PMID:23601051). It is reported that PABPN1 is ubiquitously expressed in almost all tissues, however, mutations in PABPN1 causes Oculopharyngeal Muscular Dystrophy (OPMD) which affected in skeletal muscles specifically. Because of a mild reduction in PABPN1 levels is sufficient to induce muscle wasting (PMID:27152426). Acetylation, Methylation, Phosphoprotein are common post-translational modifications of PABPN1 protein. And 50-55 kDa bands have been reported (PMID: 29939290; 28361972).

























